Cerebrolysin Dosage Guide
Complete guide to Cerebrolysin dosing protocols, administration methods, and safety considerations for research purposes.
Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.
Recommended Dosage
Clinical dosing: 10-30ml IV daily for acute conditions. Research use: 5-10ml IM daily for cognitive enhancement. Treatment courses typically last 10-20 days.
Administration Method
Administered via intramuscular or intravenous injection. IV administration is typically used in clinical settings. IM can be used for research purposes.
Side Effects to Monitor
Generally well-tolerated. May cause dizziness, headache, sweating, or injection site reactions. Rare cases of agitation or confusion.
Safety Considerations & Risks
Not FDA-approved in the US. Should be avoided in severe renal impairment and epilepsy. Quality and sourcing concerns outside clinical settings.